IMMUNEONCO-B News

IMMUNEONCO-B: INSIDE INFORMATION - ISSUANCE OF FILING NOTICE BY THE CSRC FOR THE H SHARE FULL CIRCULATION OF CERTAIN UNLISTED SHARES OF THE COMPANY

May 29 10:47 ET

IMMUNEONCO-B: List of Directors and their Role and Function

May 28 08:09 ET

IMMUNEONCO-B: I. POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON MAY 28, 2024; II. APPOINTMENT OF DIRECTOR

May 28 08:05 ET

IMMUNEONCO-B: VOLUNTARY ANNOUNCEMENT - APPROVAL BY NMPA FOR A RANDOMIZED, DOUBLEBLIND, CONTROLLED PHASE III CLINICAL TRIAL OF IMM01 (TIMDARPACEPT) IN COMBINATION WITH AZACITIDINE

May 17 04:32 ET

IMMUNEONCO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 April 2024

May 7 04:14 ET

IMMUNEONCO-B: Proxy Form for the Annual General Meeting to be held on May 28, 2024

Apr 29 06:57 ET

IMMUNEONCO-B: NOTICE OF THE ANNUAL GENERAL MEETING

Apr 29 06:54 ET

IMMUNEONCO-B: (1) 2023 WORK REPORT OF THE BOARD OF DIRECTORS; (2) 2023 WORK REPORT OF THE SUPERVISORY COMMITTEE; (3) 2023 ANNUAL REPORT; (4) 2023 FINAL FINANCIAL REPORT AND 2024 FINANCIAL BUDGET REPORT; (5) 2023 PROFIT DISTRIBUTION PLAN; (6) APPOINTMENT OF EXECUTIVE DIR

Apr 29 06:51 ET

IMMUNEONCO-B: Annual Report 2023

Apr 26 09:49 ET

IMMUNEONCO-B: VOLUNTARY ANNOUNCEMENT - APPROVAL BY NMPA FOR THE PHASE III CLINICAL TRIAL PROTOCOL OF IMM01 (TIMDARPACEPT)

Apr 17 06:16 ET

IMMUNEONCO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 March 2024

Apr 8 00:01 ET

IMMUNEONCO-B: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2023

Mar 25 10:29 ET

IMMUNEONCO-B: DATE OF BOARD MEETING

Mar 13 05:48 ET

IMMUNEONCO-B: VOLUNTARY ANNOUNCEMENT - UNUSUAL PRICE MOVEMENTS

Mar 6 09:19 ET

IMMUNEONCO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 29 February 2024

Mar 4 03:59 ET

IMMUNEONCO-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

Mar 3 18:06 ET

IMMUNEONCO-B: (1) RESIGNATION OF EXECUTIVE DIRECTOR, CHIEF FINANCIAL OFFICER AND AUTHORIZED REPRESENTATIVE; (2) PROPOSED APPOINTMENT OF EXECUTIVE DIRECTOR; AND (3) APPOINTMENT OF AUTHORIZED REPRESENTATIVE

Mar 1 09:00 ET

IMMUNEONCO-B: Notification Letter and Reply Form to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications

Feb 20 03:36 ET

IMMUNEONCO-B: Notification Letter and Reply Form to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications

Feb 20 03:31 ET

IMMUNEONCO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 January 2024

Feb 4 22:32 ET